Generics
Dr. Reddy's Laboratories Launches Generic Version of Ciprodex Otic Suspension, USP in the US Market
12 August 2020 - - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP...
Dr Reddy's Laboratories announces first-to-market generic Ciprofloxacin 0.3% and Dexamethasone USP in the US
11 August 2020 - Pharmaceutical company Dr Reddy's Laboratories Ltd (BSE:500124) (NSE:DRREDDY) (NYSE:RDY) on Monday announced the availability of the US Food and Drug Administration (USFDA) appro...
ViiV Healthcare Wins FDA Nod of Expanded Dovato Indication
7 August 2020 - - The US Food and Drug Administration approved Dovato (dolutegravir/lamivudine) as a complete regimen for the treatment of HIV-1 infection to replace the current antiretroviral regimen...
Covistat to develop low cost treatment for COVID-19 treatment in partnership with Mucokinetica
7 August 2020 - Biopharmaceutical company Covistat said on Thursday that it is one step closer in developing the low cost treatment nafamostat for COVID-19 via the acquisition of the technology and in...
Lannett unveils FDA approved levothyroxine tablets in the US thyroid market
4 August 2020 - Lannett Company Inc (NYSE:LCI) reported on Monday the availability of Cediprof Inc's US FDA approved levothyroxine Sodium Tablets USP under an interim exclusive supply and distrib...
Sesen Bio Inks Exclusive License Agreement with Qilu Pharmaceutical for the Development and Commercialisation of Vicineum in Greater China
3 August 2020 - - US-based late-stage clinical company Sesen Bio (NASDAQ: SESN) and China-based pharmaceutical company Qilu Pharmaceutical have entered into an exclusive licensing agreement for t...